ProSign in

Smart-money news

What whales, hedge funds and billionaires are doing right now — from official filings

All smart-money news
Funds & billionairesJul 2, 2026

Michael Burry Bets on Tech: Opens Positions in Palantir and Nvidia, Exits Healthcare Companies

The 'Big Short' investor makes significant investments in technology companies, while divesting his healthcare holdings.

Tickers in this story:$PLTR$NVDA$UNH$REGN

Michael Burry, the renowned investor from 'The Big Short,' revealed interesting changes in Scion Asset Management's portfolio through the 13F filing for the quarter ended September 30, 2025. Burry opened new positions in Palantir Technologies Inc. ($PLTR) valued at $912 million and NVIDIA Corporation ($NVDA) valued at $187 million. Concurrently, he sold all his holdings in UnitedHealth Group Inc. ($UNH), which were valued at $115 million, and Regeneron Pharmaceuticals ($REGN), valued at $113 million.

Michael Burry is known for his contrarian approach and in-depth market analysis. The entry into Palantir, a data analytics company, and Nvidia, a leader in chips and AI, indicates a strong belief in technological growth potential. The exit from healthcare companies may reflect a re-evaluation of the sector or a search for better opportunities elsewhere. It is important to remember that 13F filings provide a quarterly snapshot and are submitted with a delay of up to 45 days.

Individual investors can learn from Burry's moves about the importance of deep analysis and the ability to identify opportunities even in seemingly saturated sectors. Burry's approach demonstrates that even investors with a track record of betting against the current are willing to embrace growing technologies when they believe in their potential. However, it is important to remember that these filings present past data and do not indicate future transactions or the investor's current intentions.

Stories are auto-written from official filings (SEC, congressional disclosures, USAspending) and financial press, with AI assistance. Inaccuracies are possible; 13F filings lag by up to 45 days. For research only — not investment advice or a recommendation.